GT
Glenmede Trust Portfolio holdings
AUM
$18.6B
1-Year Return
8.78%
This Quarter Return
+7.42%
1 Year Return
+8.78%
3 Year Return
+33.81%
5 Year Return
+160.7%
10 Year Return
+249.02%
AUM
$19.3B
AUM Growth
+$783M
(+4.2%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-2.42%
Top 10 Holdings %
Top 10 Hldgs %
20.28%
Holding
1,341
New
146
Increased
332
Reduced
638
Closed
74
Top Buys
| 1 |
TJX Companies
TJX
|
+$36.7M |
| 2 |
Progressive
PGR
|
+$34.5M |
| 3 |
Revvity
RVTY
|
+$26.5M |
| 4 |
Northrop Grumman
NOC
|
+$24.8M |
| 5 |
Carrier Global
CARR
|
+$24.4M |
Top Sells
| 1 |
McKesson
MCK
|
+$82.1M |
| 2 |
Fortinet
FTNT
|
+$40.4M |
| 3 |
Ameriprise Financial
AMP
|
+$35.5M |
| 4 |
Broadstone Net Lease
BNL
|
+$32.8M |
| 5 |
Cadence Design Systems
CDNS
|
+$32M |
Sector Composition
| 1 | Technology | 22.44% |
| 2 | Healthcare | 12.4% |
| 3 | Financials | 11.64% |
| 4 | Consumer Discretionary | 9.19% |
| 5 | Industrials | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
HEICO
HEI
$44.1B
| $427K | ﹤0.01% |
3,068
+35
| +1% | +$4.87K |
|
927
Uber
UBER
$196B
| $424K | ﹤0.01% |
8,486
-96
| -1% | -$4.8K |
|
928
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| $422K | ﹤0.01% |
+30,559
| New | +$422K |
|
929
ESCO Technologies
ESE
$5.3B
| $421K | ﹤0.01% |
4,488
-6,751
| -60% | -$633K |
|
930
Southern Copper
SCCO
$82.9B
| $421K | ﹤0.01% |
6,894
-170
| -2% | -$10.4K |
|
931
Moderna
MRNA
$9.46B
| $419K | ﹤0.01% |
1,788
-2,050
| -53% | -$480K |
|
932
Teladoc Health
TDOC
$1.32B
| $417K | ﹤0.01% |
2,518
-52
| -2% | -$8.61K |
|
933
ePlus
PLUS
$1.93B
| $416K | ﹤0.01% |
9,614
+292
| +3% | +$12.6K |
|
934
iShares Global 100 ETF
IOO
$7.12B
| $415K | ﹤0.01% |
5,850
| – | – |
|
|
SLAM
935
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
| $413K | ﹤0.01% |
+42,660
| New | +$413K |
|
936
Mohawk Industries
MHK
$8.41B
| $411K | ﹤0.01% |
2,140
-375
| -15% | -$72K |
|
937
Rogers Corp
ROG
$1.44B
| $411K | ﹤0.01% |
2,050
-92
| -4% | -$18.4K |
|
938
AerCap
AER
$21.7B
| $410K | ﹤0.01% |
8,017
| – | – |
|
939
Invesco Biotechnology & Genome ETF
PBE
$223M
| $409K | ﹤0.01% |
5,299
-1,280
| -19% | -$98.8K |
|
940
Keurig Dr Pepper
KDP
$37.3B
| $407K | ﹤0.01% |
11,569
+259
| +2% | +$9.11K |
|
941
EOG Resources
EOG
$65.7B
| $406K | ﹤0.01% |
4,886
-296
| -6% | -$24.6K |
|
|
VIVO
942
DELISTED
Meridian Bioscience Inc
VIVO
| $406K | ﹤0.01% |
18,320
-882
| -5% | -$19.5K |
|
943
Nuveen Select Tax-Free Income Portfolio
NXP
$738M
| $405K | ﹤0.01% |
22,195
| – | – |
|
944
Hologic
HOLX
$14.6B
| $402K | ﹤0.01% |
6,036
-261
| -4% | -$17.4K |
|
945
Wabtec
WAB
$32.4B
| $400K | ﹤0.01% |
4,872
-83
| -2% | -$6.81K |
|
946
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.29B
| $399K | ﹤0.01% |
3,885
-380
| -9% | -$39K |
|
947
Douglas Dynamics
PLOW
$751M
| $399K | ﹤0.01% |
9,824
-265
| -3% | -$10.8K |
|
948
iShares Preferred and Income Securities ETF
PFF
$14.6B
| $397K | ﹤0.01% |
10,130
+1,340
| +15% | +$52.5K |
|
|
JNPR
949
DELISTED
Juniper Networks
JNPR
| $396K | ﹤0.01% |
14,546
-21,178
| -59% | -$577K |
|
950
CRISPR Therapeutics
CRSP
$4.71B
| $394K | ﹤0.01% |
2,441
-22
| -0.9% | -$3.55K |
|